nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Mitomycin—stomach cancer	0.301	0.483	CbGbCtD
Ticagrelor—ABCB1—Irinotecan—stomach cancer	0.0773	0.124	CbGbCtD
Ticagrelor—ABCB1—Docetaxel—stomach cancer	0.0566	0.0908	CbGbCtD
Ticagrelor—CYP3A4—Irinotecan—stomach cancer	0.0463	0.0742	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—stomach cancer	0.0422	0.0677	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—stomach cancer	0.0409	0.0656	CbGbCtD
Ticagrelor—CYP3A4—Docetaxel—stomach cancer	0.0339	0.0544	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—stomach cancer	0.0253	0.0406	CbGbCtD
Ticagrelor—P2RY12—hematopoietic system—stomach cancer	0.00225	0.252	CbGeAlD
Ticagrelor—P2RY12—epithelium—stomach cancer	0.00206	0.23	CbGeAlD
Ticagrelor—P2RY12—endocrine gland—stomach cancer	0.00129	0.145	CbGeAlD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000552	0.00164	CcSEcCtD
Ticagrelor—Mediastinal disorder—Docetaxel—stomach cancer	0.000551	0.00164	CcSEcCtD
Ticagrelor—Cardiac disorder—Capecitabine—stomach cancer	0.00055	0.00164	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000543	0.00162	CcSEcCtD
Ticagrelor—Fatigue—Irinotecan—stomach cancer	0.000542	0.00161	CcSEcCtD
Ticagrelor—Paraesthesia—Fluorouracil—stomach cancer	0.000541	0.00161	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—stomach cancer	0.000539	0.0016	CcSEcCtD
Ticagrelor—Constipation—Irinotecan—stomach cancer	0.000538	0.0016	CcSEcCtD
Ticagrelor—Angiopathy—Capecitabine—stomach cancer	0.000538	0.0016	CcSEcCtD
Ticagrelor—Dyspnoea—Fluorouracil—stomach cancer	0.000537	0.0016	CcSEcCtD
Ticagrelor—Mental disorder—Docetaxel—stomach cancer	0.000536	0.0016	CcSEcCtD
Ticagrelor—Immune system disorder—Capecitabine—stomach cancer	0.000535	0.00159	CcSEcCtD
Ticagrelor—Mediastinal disorder—Capecitabine—stomach cancer	0.000534	0.00159	CcSEcCtD
Ticagrelor—Malnutrition—Docetaxel—stomach cancer	0.000533	0.00158	CcSEcCtD
Ticagrelor—Dyspepsia—Fluorouracil—stomach cancer	0.00053	0.00158	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—stomach cancer	0.000528	0.00157	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00052	0.00155	CcSEcCtD
Ticagrelor—ABCB1—blood vessel—stomach cancer	0.00052	0.0581	CbGeAlD
Ticagrelor—Mental disorder—Capecitabine—stomach cancer	0.000519	0.00154	CcSEcCtD
Ticagrelor—Feeling abnormal—Irinotecan—stomach cancer	0.000518	0.00154	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—stomach cancer	0.000517	0.00154	CcSEcCtD
Ticagrelor—Malnutrition—Capecitabine—stomach cancer	0.000516	0.00153	CcSEcCtD
Ticagrelor—Back pain—Docetaxel—stomach cancer	0.000515	0.00153	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Irinotecan—stomach cancer	0.000514	0.00153	CcSEcCtD
Ticagrelor—Back pain—Capecitabine—stomach cancer	0.000499	0.00148	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—stomach cancer	0.000499	0.00148	CcSEcCtD
Ticagrelor—Body temperature increased—Irinotecan—stomach cancer	0.000497	0.00148	CcSEcCtD
Ticagrelor—Abdominal pain—Irinotecan—stomach cancer	0.000497	0.00148	CcSEcCtD
Ticagrelor—Feeling abnormal—Fluorouracil—stomach cancer	0.000496	0.00148	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—stomach cancer	0.000489	0.00145	CcSEcCtD
Ticagrelor—Syncope—Docetaxel—stomach cancer	0.000478	0.00142	CcSEcCtD
Ticagrelor—Body temperature increased—Fluorouracil—stomach cancer	0.000476	0.00142	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—stomach cancer	0.000468	0.00139	CcSEcCtD
Ticagrelor—Loss of consciousness—Docetaxel—stomach cancer	0.000468	0.00139	CcSEcCtD
Ticagrelor—Cough—Docetaxel—stomach cancer	0.000465	0.00138	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—stomach cancer	0.000463	0.00138	CcSEcCtD
Ticagrelor—Vertigo—Capecitabine—stomach cancer	0.000463	0.00138	CcSEcCtD
Ticagrelor—Hypersensitivity—Irinotecan—stomach cancer	0.000463	0.00138	CcSEcCtD
Ticagrelor—Syncope—Capecitabine—stomach cancer	0.000462	0.00138	CcSEcCtD
Ticagrelor—Hypertension—Docetaxel—stomach cancer	0.00046	0.00137	CcSEcCtD
Ticagrelor—Chest pain—Docetaxel—stomach cancer	0.000453	0.00135	CcSEcCtD
Ticagrelor—Loss of consciousness—Capecitabine—stomach cancer	0.000453	0.00135	CcSEcCtD
Ticagrelor—Asthenia—Irinotecan—stomach cancer	0.000451	0.00134	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00045	0.00134	CcSEcCtD
Ticagrelor—Cough—Capecitabine—stomach cancer	0.00045	0.00134	CcSEcCtD
Ticagrelor—Hypertension—Capecitabine—stomach cancer	0.000445	0.00132	CcSEcCtD
Ticagrelor—Hypersensitivity—Fluorouracil—stomach cancer	0.000444	0.00132	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—stomach cancer	0.000443	0.00132	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—stomach cancer	0.000441	0.00131	CcSEcCtD
Ticagrelor—Chest pain—Capecitabine—stomach cancer	0.000439	0.00131	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—stomach cancer	0.000438	0.0013	CcSEcCtD
Ticagrelor—Confusional state—Docetaxel—stomach cancer	0.000438	0.0013	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000436	0.0013	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—stomach cancer	0.000436	0.0013	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—stomach cancer	0.000434	0.00129	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—stomach cancer	0.000432	0.00129	CcSEcCtD
Ticagrelor—Diarrhoea—Irinotecan—stomach cancer	0.00043	0.00128	CcSEcCtD
Ticagrelor—Shock—Docetaxel—stomach cancer	0.000428	0.00127	CcSEcCtD
Ticagrelor—Nervous system disorder—Docetaxel—stomach cancer	0.000426	0.00127	CcSEcCtD
Ticagrelor—Pruritus—Fluorouracil—stomach cancer	0.000426	0.00127	CcSEcCtD
Ticagrelor—Confusional state—Capecitabine—stomach cancer	0.000424	0.00126	CcSEcCtD
Ticagrelor—Skin disorder—Docetaxel—stomach cancer	0.000422	0.00126	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—stomach cancer	0.00042	0.00125	CcSEcCtD
Ticagrelor—Dizziness—Irinotecan—stomach cancer	0.000416	0.00124	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—stomach cancer	0.000415	0.00123	CcSEcCtD
Ticagrelor—Shock—Capecitabine—stomach cancer	0.000414	0.00123	CcSEcCtD
Ticagrelor—Nervous system disorder—Capecitabine—stomach cancer	0.000413	0.00123	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—stomach cancer	0.000413	0.00123	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—stomach cancer	0.000412	0.00123	CcSEcCtD
Ticagrelor—Diarrhoea—Fluorouracil—stomach cancer	0.000412	0.00123	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—stomach cancer	0.000409	0.00122	CcSEcCtD
Ticagrelor—Skin disorder—Capecitabine—stomach cancer	0.000409	0.00122	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—stomach cancer	0.000408	0.00121	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—stomach cancer	0.000407	0.00121	CcSEcCtD
Ticagrelor—Hypotension—Docetaxel—stomach cancer	0.000406	0.00121	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—stomach cancer	0.000406	0.00121	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—stomach cancer	0.000406	0.00121	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—stomach cancer	0.000405	0.0012	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—stomach cancer	0.000401	0.00119	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—stomach cancer	0.0004	0.00119	CcSEcCtD
Ticagrelor—Vomiting—Irinotecan—stomach cancer	0.0004	0.00119	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—stomach cancer	0.000398	0.00119	CcSEcCtD
Ticagrelor—Dizziness—Fluorouracil—stomach cancer	0.000398	0.00119	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—stomach cancer	0.000397	0.00118	CcSEcCtD
Ticagrelor—Rash—Irinotecan—stomach cancer	0.000397	0.00118	CcSEcCtD
Ticagrelor—Dermatitis—Irinotecan—stomach cancer	0.000396	0.00118	CcSEcCtD
Ticagrelor—Headache—Irinotecan—stomach cancer	0.000394	0.00117	CcSEcCtD
Ticagrelor—Hypotension—Capecitabine—stomach cancer	0.000393	0.00117	CcSEcCtD
Ticagrelor—CYP3A4—hematopoietic system—stomach cancer	0.000391	0.0437	CbGeAlD
Ticagrelor—Paraesthesia—Docetaxel—stomach cancer	0.00039	0.00116	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—stomach cancer	0.000389	0.00116	CcSEcCtD
Ticagrelor—Dyspnoea—Docetaxel—stomach cancer	0.000388	0.00115	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—stomach cancer	0.000386	0.00115	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—stomach cancer	0.000386	0.00115	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—stomach cancer	0.000384	0.00114	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—stomach cancer	0.000384	0.00114	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—stomach cancer	0.000383	0.00114	CcSEcCtD
Ticagrelor—Vomiting—Fluorouracil—stomach cancer	0.000383	0.00114	CcSEcCtD
Ticagrelor—Dyspepsia—Docetaxel—stomach cancer	0.000383	0.00114	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—stomach cancer	0.000382	0.00114	CcSEcCtD
Ticagrelor—Rash—Fluorouracil—stomach cancer	0.00038	0.00113	CcSEcCtD
Ticagrelor—Dermatitis—Fluorouracil—stomach cancer	0.000379	0.00113	CcSEcCtD
Ticagrelor—Paraesthesia—Capecitabine—stomach cancer	0.000378	0.00112	CcSEcCtD
Ticagrelor—Headache—Fluorouracil—stomach cancer	0.000377	0.00112	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—stomach cancer	0.000377	0.00112	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—stomach cancer	0.000376	0.00112	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000375	0.00112	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—stomach cancer	0.000375	0.00112	CcSEcCtD
Ticagrelor—Dyspnoea—Capecitabine—stomach cancer	0.000375	0.00112	CcSEcCtD
Ticagrelor—Fatigue—Docetaxel—stomach cancer	0.000375	0.00112	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—stomach cancer	0.000374	0.00111	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—stomach cancer	0.000374	0.00111	CcSEcCtD
Ticagrelor—Nausea—Irinotecan—stomach cancer	0.000374	0.00111	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—stomach cancer	0.000373	0.00111	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—stomach cancer	0.000372	0.00111	CcSEcCtD
Ticagrelor—Constipation—Docetaxel—stomach cancer	0.000372	0.00111	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—stomach cancer	0.000371	0.0011	CcSEcCtD
Ticagrelor—Dyspepsia—Capecitabine—stomach cancer	0.00037	0.0011	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000363	0.00108	CcSEcCtD
Ticagrelor—Fatigue—Capecitabine—stomach cancer	0.000363	0.00108	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—stomach cancer	0.000362	0.00108	CcSEcCtD
Ticagrelor—Constipation—Capecitabine—stomach cancer	0.00036	0.00107	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—stomach cancer	0.000359	0.00107	CcSEcCtD
Ticagrelor—Feeling abnormal—Docetaxel—stomach cancer	0.000358	0.00107	CcSEcCtD
Ticagrelor—Nausea—Fluorouracil—stomach cancer	0.000358	0.00106	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—stomach cancer	0.000357	0.00106	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Docetaxel—stomach cancer	0.000355	0.00106	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—stomach cancer	0.000354	0.00105	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—stomach cancer	0.000348	0.00103	CcSEcCtD
Ticagrelor—Feeling abnormal—Capecitabine—stomach cancer	0.000347	0.00103	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—stomach cancer	0.000346	0.00103	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—stomach cancer	0.000345	0.00103	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—stomach cancer	0.000345	0.00103	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Capecitabine—stomach cancer	0.000344	0.00102	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—stomach cancer	0.000344	0.00102	CcSEcCtD
Ticagrelor—Abdominal pain—Docetaxel—stomach cancer	0.000344	0.00102	CcSEcCtD
Ticagrelor—Body temperature increased—Docetaxel—stomach cancer	0.000344	0.00102	CcSEcCtD
Ticagrelor—Cough—Methotrexate—stomach cancer	0.000335	0.000997	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—stomach cancer	0.000335	0.000996	CcSEcCtD
Ticagrelor—Body temperature increased—Capecitabine—stomach cancer	0.000333	0.00099	CcSEcCtD
Ticagrelor—Abdominal pain—Capecitabine—stomach cancer	0.000333	0.00099	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—stomach cancer	0.000332	0.000989	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—stomach cancer	0.000327	0.000973	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000325	0.000966	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—stomach cancer	0.000323	0.00096	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—stomach cancer	0.000322	0.000959	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—stomach cancer	0.000322	0.000957	CcSEcCtD
Ticagrelor—Hypersensitivity—Docetaxel—stomach cancer	0.00032	0.000953	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—stomach cancer	0.000316	0.00094	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—stomach cancer	0.000316	0.00094	CcSEcCtD
Ticagrelor—Cough—Epirubicin—stomach cancer	0.000314	0.000933	CcSEcCtD
Ticagrelor—Asthenia—Docetaxel—stomach cancer	0.000312	0.000928	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—stomach cancer	0.00031	0.000923	CcSEcCtD
Ticagrelor—Hypersensitivity—Capecitabine—stomach cancer	0.00031	0.000923	CcSEcCtD
Ticagrelor—Pruritus—Docetaxel—stomach cancer	0.000308	0.000915	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—stomach cancer	0.000307	0.000914	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—stomach cancer	0.000306	0.00091	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—stomach cancer	0.000304	0.000906	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000304	0.000904	CcSEcCtD
Ticagrelor—Asthenia—Capecitabine—stomach cancer	0.000302	0.000899	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—stomach cancer	0.000299	0.000889	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—stomach cancer	0.000298	0.000887	CcSEcCtD
Ticagrelor—Pruritus—Capecitabine—stomach cancer	0.000298	0.000886	CcSEcCtD
Ticagrelor—Diarrhoea—Docetaxel—stomach cancer	0.000297	0.000885	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—stomach cancer	0.000296	0.00088	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—stomach cancer	0.000293	0.000871	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—stomach cancer	0.000292	0.000869	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—stomach cancer	0.00029	0.000863	CcSEcCtD
Ticagrelor—Shock—Epirubicin—stomach cancer	0.000288	0.000858	CcSEcCtD
Ticagrelor—Diarrhoea—Capecitabine—stomach cancer	0.000288	0.000857	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—stomach cancer	0.000288	0.000856	CcSEcCtD
Ticagrelor—Dizziness—Docetaxel—stomach cancer	0.000287	0.000855	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—stomach cancer	0.000287	0.000854	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—stomach cancer	0.000285	0.000847	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—stomach cancer	0.000283	0.000842	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—stomach cancer	0.000281	0.000837	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000281	0.000836	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—stomach cancer	0.000279	0.000831	CcSEcCtD
Ticagrelor—Dizziness—Capecitabine—stomach cancer	0.000278	0.000828	CcSEcCtD
Ticagrelor—ABCB1—hematopoietic system—stomach cancer	0.000277	0.031	CbGeAlD
Ticagrelor—Vomiting—Docetaxel—stomach cancer	0.000276	0.000822	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—stomach cancer	0.000276	0.000821	CcSEcCtD
Ticagrelor—Rash—Docetaxel—stomach cancer	0.000274	0.000816	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—stomach cancer	0.000274	0.000815	CcSEcCtD
Ticagrelor—Dermatitis—Docetaxel—stomach cancer	0.000274	0.000815	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—stomach cancer	0.000274	0.000814	CcSEcCtD
Ticagrelor—Headache—Docetaxel—stomach cancer	0.000272	0.00081	CcSEcCtD
Ticagrelor—CYP3A4—digestive system—stomach cancer	0.000272	0.0304	CbGeAlD
Ticagrelor—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000271	0.000805	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—stomach cancer	0.00027	0.000804	CcSEcCtD
Ticagrelor—Vomiting—Capecitabine—stomach cancer	0.000268	0.000796	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—stomach cancer	0.000267	0.000794	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—stomach cancer	0.000266	0.000792	CcSEcCtD
Ticagrelor—Rash—Capecitabine—stomach cancer	0.000265	0.00079	CcSEcCtD
Ticagrelor—Dermatitis—Capecitabine—stomach cancer	0.000265	0.000789	CcSEcCtD
Ticagrelor—Headache—Capecitabine—stomach cancer	0.000264	0.000785	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—stomach cancer	0.000264	0.000784	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—stomach cancer	0.000263	0.000783	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—stomach cancer	0.000261	0.000778	CcSEcCtD
Ticagrelor—Nausea—Docetaxel—stomach cancer	0.000258	0.000768	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—stomach cancer	0.000258	0.000768	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—stomach cancer	0.000258	0.000768	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—stomach cancer	0.000256	0.000762	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—stomach cancer	0.000254	0.000754	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000253	0.000753	CcSEcCtD
Ticagrelor—ABCB1—epithelium—stomach cancer	0.000253	0.0283	CbGeAlD
Ticagrelor—Fatigue—Epirubicin—stomach cancer	0.000253	0.000752	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—stomach cancer	0.000251	0.000746	CcSEcCtD
Ticagrelor—Nausea—Capecitabine—stomach cancer	0.00025	0.000744	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—stomach cancer	0.000248	0.000737	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—stomach cancer	0.000248	0.000737	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—stomach cancer	0.000244	0.000725	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—stomach cancer	0.000242	0.00072	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—stomach cancer	0.000242	0.000719	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—stomach cancer	0.00024	0.000713	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—stomach cancer	0.000239	0.000711	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000234	0.000697	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—stomach cancer	0.000234	0.000696	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—stomach cancer	0.000232	0.00069	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—stomach cancer	0.000232	0.00069	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—stomach cancer	0.000232	0.00069	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—stomach cancer	0.000231	0.000687	CcSEcCtD
Ticagrelor—ABCB1—pancreas—stomach cancer	0.000225	0.0252	CbGeAlD
Ticagrelor—Asthenia—Methotrexate—stomach cancer	0.000225	0.000669	CcSEcCtD
Ticagrelor—CYP3A4—endocrine gland—stomach cancer	0.000225	0.0251	CbGeAlD
Ticagrelor—Feeling abnormal—Doxorubicin—stomach cancer	0.000224	0.000665	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000222	0.00066	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—stomach cancer	0.000222	0.00066	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—stomach cancer	0.000216	0.000643	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—stomach cancer	0.000214	0.000638	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—stomach cancer	0.000214	0.000638	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—stomach cancer	0.000214	0.000638	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—stomach cancer	0.00021	0.000626	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—stomach cancer	0.000207	0.000617	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—stomach cancer	0.000207	0.000617	CcSEcCtD
Ticagrelor—CYP3A4—liver—stomach cancer	0.000203	0.0227	CbGeAlD
Ticagrelor—Diarrhoea—Epirubicin—stomach cancer	0.000201	0.000597	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—stomach cancer	0.0002	0.000595	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—stomach cancer	0.000199	0.000593	CcSEcCtD
Ticagrelor—Rash—Methotrexate—stomach cancer	0.000198	0.000588	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—stomach cancer	0.000197	0.000587	CcSEcCtD
Ticagrelor—Headache—Methotrexate—stomach cancer	0.000196	0.000584	CcSEcCtD
Ticagrelor—ABCB1—lymphoid tissue—stomach cancer	0.000195	0.0218	CbGeAlD
Ticagrelor—Asthenia—Doxorubicin—stomach cancer	0.000195	0.000579	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—stomach cancer	0.000194	0.000577	CcSEcCtD
Ticagrelor—ABCB1—digestive system—stomach cancer	0.000193	0.0215	CbGeAlD
Ticagrelor—Pruritus—Doxorubicin—stomach cancer	0.000192	0.000571	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—stomach cancer	0.000186	0.000555	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—stomach cancer	0.000186	0.000554	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—stomach cancer	0.000186	0.000552	CcSEcCtD
Ticagrelor—Rash—Epirubicin—stomach cancer	0.000185	0.00055	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—stomach cancer	0.000185	0.00055	CcSEcCtD
Ticagrelor—Headache—Epirubicin—stomach cancer	0.000184	0.000547	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—stomach cancer	0.000179	0.000534	CcSEcCtD
Ticagrelor—ABCB1—bone marrow—stomach cancer	0.000177	0.0198	CbGeAlD
Ticagrelor—Nausea—Epirubicin—stomach cancer	0.000174	0.000518	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—stomach cancer	0.000173	0.000513	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—stomach cancer	0.000171	0.000509	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—stomach cancer	0.000171	0.000509	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—stomach cancer	0.00017	0.000506	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—stomach cancer	0.000161	0.00048	CcSEcCtD
Ticagrelor—ABCB1—endocrine gland—stomach cancer	0.000159	0.0178	CbGeAlD
Ticagrelor—ABCB1—liver—stomach cancer	0.000143	0.016	CbGeAlD
Ticagrelor—ABCB1—lymph node—stomach cancer	0.00011	0.0123	CbGeAlD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR1A—stomach cancer	9.74e-05	0.00311	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	9.57e-05	0.00306	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ANXA1—stomach cancer	9.4e-05	0.003	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—WIF1—stomach cancer	9.34e-05	0.00298	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRH4—stomach cancer	9.34e-05	0.00298	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGTR2—stomach cancer	9.19e-05	0.00293	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB1—stomach cancer	9.11e-05	0.00291	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—F2R—stomach cancer	9.08e-05	0.0029	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	9.06e-05	0.00289	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	8.89e-05	0.00284	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR1A—stomach cancer	8.84e-05	0.00282	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKAB1—stomach cancer	8.62e-05	0.00275	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLAU—stomach cancer	8.61e-05	0.00275	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	8.59e-05	0.00274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ANXA1—stomach cancer	8.54e-05	0.00273	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CAV1—stomach cancer	8.41e-05	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	8.41e-05	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—APOA1—stomach cancer	8.39e-05	0.00268	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KISS1—stomach cancer	8.33e-05	0.00266	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RNF43—stomach cancer	8.33e-05	0.00266	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	8.28e-05	0.00265	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB1—stomach cancer	8.27e-05	0.00264	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PRKCB—stomach cancer	8e-05	0.00256	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	8e-05	0.00256	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	7.87e-05	0.00251	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	7.75e-05	0.00248	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FST—stomach cancer	7.42e-05	0.00237	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	7.39e-05	0.00236	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRB2—stomach cancer	7.38e-05	0.00236	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HBEGF—stomach cancer	7.26e-05	0.00232	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RGS2—stomach cancer	7.16e-05	0.00229	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GAST—stomach cancer	7.16e-05	0.00229	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	7.06e-05	0.00225	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	6.94e-05	0.00222	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CASP8—stomach cancer	6.85e-05	0.00219	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGG—stomach cancer	6.79e-05	0.00217	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	6.72e-05	0.00215	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRB2—stomach cancer	6.7e-05	0.00214	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—stomach cancer	6.66e-05	0.00213	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—stomach cancer	6.65e-05	0.00212	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PPP2R1A—stomach cancer	6.57e-05	0.0021	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKAA1—stomach cancer	6.53e-05	0.00209	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—RHOA—stomach cancer	6.42e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS3—stomach cancer	6.36e-05	0.00203	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RBP4—stomach cancer	6.31e-05	0.00202	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—stomach cancer	6.31e-05	0.00201	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	6.14e-05	0.00196	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	5.93e-05	0.0019	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	5.82e-05	0.00186	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGTR2—stomach cancer	5.43e-05	0.00173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HSPB1—stomach cancer	5.43e-05	0.00173	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—stomach cancer	5.42e-05	0.00173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—F2R—stomach cancer	5.37e-05	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BMP2—stomach cancer	5.37e-05	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKR1C3—stomach cancer	5.28e-05	0.00169	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR1A—stomach cancer	5.22e-05	0.00167	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—stomach cancer	5.2e-05	0.00166	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTT1—stomach cancer	5.14e-05	0.00164	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	5.12e-05	0.00164	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	5.08e-05	0.00162	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	5.08e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PRKCB—stomach cancer	5.06e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ANXA1—stomach cancer	5.04e-05	0.00161	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	5.04e-05	0.00161	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACAD8—stomach cancer	4.98e-05	0.00159	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	4.95e-05	0.00158	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRB1—stomach cancer	4.89e-05	0.00156	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	4.88e-05	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RPS6—stomach cancer	4.67e-05	0.00149	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.62e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PRKCB—stomach cancer	4.59e-05	0.00147	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—stomach cancer	4.58e-05	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6ST—stomach cancer	4.57e-05	0.00146	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GMPR2—stomach cancer	4.43e-05	0.00142	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—stomach cancer	4.4e-05	0.00141	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK3—stomach cancer	4.33e-05	0.00138	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HBEGF—stomach cancer	4.29e-05	0.00137	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK1—stomach cancer	4.12e-05	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6R—stomach cancer	4.08e-05	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—RHOA—stomach cancer	4.06e-05	0.0013	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SUCLG1—stomach cancer	4.06e-05	0.0013	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—IDH3B—stomach cancer	4.06e-05	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRB2—stomach cancer	3.96e-05	0.00126	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—KRAS—stomach cancer	3.89e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PPP2R1A—stomach cancer	3.88e-05	0.00124	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	3.86e-05	0.00123	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—stomach cancer	3.77e-05	0.0012	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NDUFV1—stomach cancer	3.77e-05	0.0012	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NDUFS1—stomach cancer	3.77e-05	0.0012	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—RHOA—stomach cancer	3.69e-05	0.00118	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	3.63e-05	0.00116	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SMAD4—stomach cancer	3.6e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CA—stomach cancer	3.58e-05	0.00114	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—stomach cancer	3.57e-05	0.00114	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—stomach cancer	3.56e-05	0.00114	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	3.52e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—stomach cancer	3.46e-05	0.00111	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FYN—stomach cancer	3.42e-05	0.00109	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	3.38e-05	0.00108	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BLVRB—stomach cancer	3.36e-05	0.00107	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PGLS—stomach cancer	3.36e-05	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—HRAS—stomach cancer	3.31e-05	0.00106	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—stomach cancer	3.28e-05	0.00105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—stomach cancer	3.24e-05	0.00103	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	3.23e-05	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGFR2—stomach cancer	3.21e-05	0.00103	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPAP2A—stomach cancer	3.21e-05	0.00102	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACAD8—stomach cancer	3.07e-05	0.000979	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS2—stomach cancer	2.94e-05	0.000939	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA1—stomach cancer	2.86e-05	0.000913	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NDUFA2—stomach cancer	2.86e-05	0.000913	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FBP1—stomach cancer	2.86e-05	0.000913	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CKB—stomach cancer	2.86e-05	0.000913	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CAV1—stomach cancer	2.85e-05	0.000911	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA1—stomach cancer	2.84e-05	0.000909	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.82e-05	0.000901	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.76e-05	0.000881	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GMPR2—stomach cancer	2.73e-05	0.000873	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCB—stomach cancer	2.71e-05	0.000867	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6ST—stomach cancer	2.7e-05	0.000863	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLIN2—stomach cancer	2.69e-05	0.000858	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CA2—stomach cancer	2.61e-05	0.000835	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.61e-05	0.000834	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—stomach cancer	2.6e-05	0.000829	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NT5E—stomach cancer	2.55e-05	0.000814	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PGAM1—stomach cancer	2.55e-05	0.000814	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—IDH3B—stomach cancer	2.5e-05	0.000798	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.5e-05	0.000798	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.49e-05	0.000796	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK3—stomach cancer	2.49e-05	0.000794	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.49e-05	0.000794	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLCE1—stomach cancer	2.43e-05	0.000776	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDH7A1—stomach cancer	2.43e-05	0.000776	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6R—stomach cancer	2.41e-05	0.00077	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.41e-05	0.00077	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK1—stomach cancer	2.37e-05	0.000756	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—stomach cancer	2.37e-05	0.000756	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.35e-05	0.000751	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UMPS—stomach cancer	2.33e-05	0.000744	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.32e-05	0.000742	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.32e-05	0.000742	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—stomach cancer	2.26e-05	0.000722	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—stomach cancer	2.26e-05	0.000721	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—stomach cancer	2.23e-05	0.000714	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RHOA—stomach cancer	2.18e-05	0.000696	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.17e-05	0.000694	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PDHA1—stomach cancer	2.17e-05	0.000692	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ECHS1—stomach cancer	2.17e-05	0.000692	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—stomach cancer	2.16e-05	0.000689	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.08e-05	0.000666	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PGLS—stomach cancer	2.07e-05	0.000662	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BLVRB—stomach cancer	2.07e-05	0.000662	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.05e-05	0.000656	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—stomach cancer	2.05e-05	0.000656	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TYMP—stomach cancer	2.04e-05	0.000651	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FADS1—stomach cancer	2.04e-05	0.000651	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—stomach cancer	2.02e-05	0.000644	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2e-05	0.000638	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.98e-05	0.000631	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.95e-05	0.000625	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.95e-05	0.000624	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—stomach cancer	1.91e-05	0.000611	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SREBF2—stomach cancer	1.91e-05	0.000609	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HRAS—stomach cancer	1.9e-05	0.000607	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RORA—stomach cancer	1.88e-05	0.000602	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1B—stomach cancer	1.87e-05	0.000596	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.86e-05	0.000595	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.85e-05	0.00059	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—stomach cancer	1.82e-05	0.000581	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCND1—stomach cancer	1.78e-05	0.000569	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JUN—stomach cancer	1.78e-05	0.000568	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDOB—stomach cancer	1.77e-05	0.000564	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA1—stomach cancer	1.76e-05	0.000562	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CKB—stomach cancer	1.76e-05	0.000562	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FBP1—stomach cancer	1.76e-05	0.000562	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.76e-05	0.000562	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—stomach cancer	1.73e-05	0.000552	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1A—stomach cancer	1.72e-05	0.00055	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.7e-05	0.000542	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK8—stomach cancer	1.68e-05	0.000537	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLIN2—stomach cancer	1.66e-05	0.000529	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5—stomach cancer	1.64e-05	0.000524	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.64e-05	0.000524	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DPYD—stomach cancer	1.61e-05	0.000516	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CA2—stomach cancer	1.61e-05	0.000514	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.58e-05	0.000505	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NT5E—stomach cancer	1.57e-05	0.000501	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PGAM1—stomach cancer	1.57e-05	0.000501	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—stomach cancer	1.55e-05	0.000496	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—stomach cancer	1.54e-05	0.000491	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.5e-05	0.000478	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLCE1—stomach cancer	1.5e-05	0.000478	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK3—stomach cancer	1.47e-05	0.000469	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UMPS—stomach cancer	1.44e-05	0.000459	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—stomach cancer	1.43e-05	0.000456	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—stomach cancer	1.43e-05	0.000456	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2A6—stomach cancer	1.41e-05	0.000451	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK1—stomach cancer	1.4e-05	0.000447	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—stomach cancer	1.4e-05	0.000446	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C3—stomach cancer	1.37e-05	0.000439	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO1—stomach cancer	1.34e-05	0.000427	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PDHA1—stomach cancer	1.33e-05	0.000426	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ECHS1—stomach cancer	1.33e-05	0.000426	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—stomach cancer	1.32e-05	0.000422	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TYMP—stomach cancer	1.25e-05	0.000401	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FADS1—stomach cancer	1.25e-05	0.000401	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.25e-05	0.0004	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—stomach cancer	1.21e-05	0.000387	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CD44—stomach cancer	1.19e-05	0.000379	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SREBF2—stomach cancer	1.17e-05	0.000375	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—stomach cancer	1.17e-05	0.000375	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RORA—stomach cancer	1.16e-05	0.000371	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRAS—stomach cancer	1.12e-05	0.000358	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDOB—stomach cancer	1.09e-05	0.000347	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—stomach cancer	1.07e-05	0.000343	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5—stomach cancer	1.01e-05	0.000323	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.01e-05	0.000322	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DPYD—stomach cancer	9.95e-06	0.000318	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—stomach cancer	9.9e-06	0.000316	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—stomach cancer	9.76e-06	0.000312	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TYMS—stomach cancer	9.2e-06	0.000294	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—stomach cancer	9.09e-06	0.000291	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—stomach cancer	8.8e-06	0.000281	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.7e-06	0.000278	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ERCC2—stomach cancer	8.55e-06	0.000273	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C3—stomach cancer	8.46e-06	0.00027	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO1—stomach cancer	8.24e-06	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—stomach cancer	8.04e-06	0.000257	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAV1—stomach cancer	7.41e-06	0.000237	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA1—stomach cancer	7.4e-06	0.000236	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CD44—stomach cancer	7.31e-06	0.000234	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—stomach cancer	6.52e-06	0.000208	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.22e-06	0.000199	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—stomach cancer	6.1e-06	0.000195	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—stomach cancer	6.01e-06	0.000192	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—stomach cancer	5.86e-06	0.000187	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TYMS—stomach cancer	5.67e-06	0.000181	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—stomach cancer	5.61e-06	0.000179	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—stomach cancer	5.6e-06	0.000179	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ERCC2—stomach cancer	5.27e-06	0.000168	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—stomach cancer	5.13e-06	0.000164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—stomach cancer	4.95e-06	0.000158	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAV1—stomach cancer	4.57e-06	0.000146	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA1—stomach cancer	4.56e-06	0.000146	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—stomach cancer	4.02e-06	0.000128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—stomach cancer	3.61e-06	0.000115	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—stomach cancer	3.45e-06	0.00011	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—stomach cancer	3.16e-06	0.000101	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—stomach cancer	3.15e-06	0.000101	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.94e-06	6.21e-05	CbGpPWpGaD
